No changes in Promoter or Institution shareholding for Prism Medico and Pharmacy Ltd., indicating a lack of confidence from smart money.

Public shareholding has increased, but this is reactive behavior rather than proactive investment, suggesting potential caution among retail investors.

In contrast, the sector averages show no movement in shareholding, aligning with Prism's stagnation, reinforcing the idea of broad-based selling across the sector.